Democrat mayors from Baltimore, Chicago, and Columbus, Ohio, have filed a lawsuit1 against the Trump administration’s rollback of access under the Affordable Care Act, alleging that the changes will ...

Background Respiratory syncytial virus (RSV) remains the leading cause of serious viral bronchiolitis and pneumonia in infants and young children throughout the world. The burden of disease is ...

Respiratory syncytial virus (RSV) is a major cause of severe lower respiratory infections for which effective treatment options remain limited. Herein, we employed a computational structure-based ...

HHS Secretary Robert F. Kennedy Jr. abruptly removed 17 vaccine experts from the CDC’s Advisory Committee on Immunization Practices on Monday — and Washington is already reeling.

Respiratory syncytial virus (RSV) infections can lead to serious complications, particularly in infants and older adults aged 75 years and above. Recent advancements in vaccine trials for older ...

Respiratory syncytial virus (RSV) is a common RNA virus that, in most people, causes mild respiratory illness. In vulnerable populations, such as infants and older people, it can cause serious illness ...

Controlling respiratory syncytial virus: real life data from Luxembourg Early data after passive immunisation with a monoclonal antibody against severe respiratory syncytial virus in 2023 show a ...

A surge of children has been hospitalized in China for respiratory illnesses, but international health authorities said the cause was common viruses and bacteria.

Discover key insights into Respiratory Syncytial Virus (RSV) — its symptoms, peak season, and how it spreads. Learn about the latest vaccines, diagnosis methods, and effective prevention and treatment ...